Последние добавленные видео:
btk-mutation
-
6 лет назад
369 6 лет назад 2:37Resistance to acalabrutinib in CLL is mediated by BTK mutations
-
1 год назад
207 1 год назад 6:11Exploring Bruton's Tyrosine Kinase (BTK) Mutations
-
1 год назад
867 1 год назад 2:36Mechanism of Bruton's Tyrosine Kinase (BTK) Mutations
-
6 лет назад
722 6 лет назад 3:57BTK Inhibitors in Chronic Lymphocytic Leukemia
-
3 недели назад
36 3 недели назад 4:13Understanding and overcoming BTK inhibitor resistance in CLL
-
6 месяцев назад
51 6 месяцев назад 1:13Breaking Resistance in Leukemia with BTK Degraders - Taylor Lab Project
-
12 дней назад
53 12 дней назад 2:19Resistance to BTK degraders and combination strategies in CLL
-
6 месяцев назад
254 6 месяцев назад 5:33Real-World Prevalence of BTK Mutations in Patients with CLL - Drs. Jennifer Woyach and Alan Skarbnik
-
1 год назад
95 1 год назад 1:12Studying mutations in the BTK gene in patients with CLL receiving BTK inhibitors
-
13 дней назад
35 13 дней назад 1:57BTK degraders: mechanism and overcoming resistance in CLL
-
3 года назад
979 3 года назад 2:23Non-covalent vs covalent BTK inhibitors in CLL
-
1 год назад
44 1 год назад 34:51Fine-Tuning Chronic Lymphocytic Leukemia Management: Optimising Bruton Tyrosine Kinase Inhibitor ...
-
6 лет назад
192 6 лет назад 2:48Second generation BTK-inhibitors for CLL
-
5 лет назад
186 5 лет назад 2:41BTK and PLCG2 mutations in CLL patients taking ibrutinib
-
6 лет назад
89 6 лет назад 4:23Other BTK Inhibitors in Chronic Lymphocytic Leukemia
-
8 месяцев назад
42 8 месяцев назад 3:47Understanding mechanisms of resistance to BTK and BCL2 inhibitors in patients with CLL
-
4 года назад
165 4 года назад 1:56BTK inhibitors and their place in the treatment landscape of B-cell malignancies
-
6 лет назад
154 6 лет назад 5:44Resistance Mechanisms Associated With BTK Inhibitors
-
6 месяцев назад
110 6 месяцев назад 1:54Targeting BTKi-resistant CLL using the 4th-generation BTK inhibitor rocbrutinib
-
3 недели назад
13 3 недели назад 1:40The evolving role of non-covalent BTK inhibitors in CLL